APA (7th ed.) Citation

Molfino, A., Imbimbo, G., Pisegna, S., Scagnoli, S., Alabiso, C., Ardovino, M., . . . Botticelli, A. (2025). Impact of Body Composition Changes on Treatment-Related Toxicities and Clinical Outcomes in HER2-Positive Metastatic Breast Cancer Patients Receiving Trastuzumab Deruxtecan. Cancers, 17(18), 3063. https://doi.org/10.3390/cancers17183063

Chicago Style (17th ed.) Citation

Molfino, Alessio, Giovanni Imbimbo, Simona Pisegna, Simone Scagnoli, Claudia Alabiso, Massimiliano Ardovino, Carmen Gallicchio, Veronica Rizzo, and Andrea Botticelli. "Impact of Body Composition Changes on Treatment-Related Toxicities and Clinical Outcomes in HER2-Positive Metastatic Breast Cancer Patients Receiving Trastuzumab Deruxtecan." Cancers 17, no. 18 (2025): 3063. https://doi.org/10.3390/cancers17183063.

MLA (9th ed.) Citation

Molfino, Alessio, et al. "Impact of Body Composition Changes on Treatment-Related Toxicities and Clinical Outcomes in HER2-Positive Metastatic Breast Cancer Patients Receiving Trastuzumab Deruxtecan." Cancers, vol. 17, no. 18, 2025, p. 3063, https://doi.org/10.3390/cancers17183063.